Publications by authors named "E Ballarin"

Claim this Profile
R
Reply to: "Effectiveness of alirocumab and evolocumab (PCSK9i) for the treatment of hypercholesterolemia".
Montserrat Bosch, Elena Ballarín, Immaculada Danés

Med Clin (Barc)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.
J Riera-Arnau, E Ballarín, R Llop, E Montané, P Hereu

Front Pharmacol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of alirocumab and evolocumab for hypercholesterolemia in a population with high cardiovascular risk.
Montserrat Bosch, Immaculada Danés, Elena Ballarín, Patricia Marrero, Guillem Vancells

Med Clin (Barc)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the Relationship between Body Image Satisfaction and Physical Activity in Italian Adolescents: A Cross-Sectional Investigation.
Sabrina Masotti, Tommaso Piva, Valentina Zerbini, Andrea Raisi, Erica Menegatti, Elena Ballarin

Children (Basel)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 and pregnancy: A European study on pre- and post-infection medication use.
Eimir Hurley, Benjamin P Geisler, Angela Lupattelli, Beatriz Poblador-Plou, Régis Lassalle

Eur J Clin Pharmacol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis